Global Alzheimer’s drugs market is projected to reach USD 7.48 billion by 2027, exhibiting a robust CAGR of 7.71% from 2022 to 2027.
Alzheimer’s, a form of dementia that affects a patient’s behavior, thinking, and memory, is a sluggish-progressing disorder that gradually deteriorates neurons associated with the gaining knowledge of part of the cerebrum. It is the most common and large form of dementia, affecting over 60% of humans aged 65 and above. However, with accelerated cognizance and […]